USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NEPHROS THERAPEUTICS, INC.
Address:
1995 HIGHLAND DR, STE F
ANN ARBOR, MI 48105
Phone:
(734) 975-0080
URL:
N/A
EIN:
383172746
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $275,000.00 4
SBIR Phase II $1,104,700.00 2

Award List:

Tissue Engineering of a Biohybrid Human Kidney Tubule

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Deborah Cieslinski
Abstract:
N/a

Tissue Engineering of a Biohybrid Human Kidney Tubule

Award Year / Program / Phase:
1996 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
HHS
Principal Investigator:
Deborah Cieslinski
Abstract:
Our research is part of an ongoing program to develop artificial equivalents of the renal glomerulipresent application will to identify the best combination of synthetic materials, biologic compoundsproduce a bioartificial renal tubule. Renal tubular progenitor cells will be grown as a confluent… More

SBIR Phase I: Erythropoientin Cell Therapy in Chronic Renal Failure

Award Year / Program / Phase:
1996 / SBIR / Phase I
Award Amount:
$75,000.00
Agency:
NSF
Principal Investigator:
Deborah Cieslinski
Abstract:
N/a

GENE THERAPY DEVICE FOR TREATMENT OF HEMOPHILIA B

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Buffington, Deborah A
Abstract:
N/a

GENE THERAPY DEVICE FOR TREATMENT OF HEMOPHILIA B

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Deborah A. Buffington
Abstract:
DESCRIPTION (Unedited Applicant's Abstract): The goal of this proposal is to develop a novel gene therapy delivery device for treatment of the genetic disorder. Hemophilia B. a devastating and costly (over a billion dollar market) disease characterized by spontaneous internal… More

GENE THERAPY DEVICE FOR TREATMENT OF HEMOPHILIA B

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$354,700.00
Agency:
HHS
Principal Investigator:
Deborah A. Buffington
Abstract:
DESCRIPTION (Unedited Applicant's Abstract): The goal of this proposal is to develop a novel gene therapy delivery device for treatment of the genetic disorder. Hemophilia B. a devastating and costly (over a billion dollar market) disease characterized by spontaneous internal… More